265 related articles for article (PubMed ID: 26679199)
1. A computational method for drug repositioning using publicly available gene expression data.
Shabana KM; Abdul Nazeer KA; Pradhan M; Palakal M
BMC Bioinformatics; 2015; 16 Suppl 17(Suppl 17):S5. PubMed ID: 26679199
[TBL] [Abstract][Full Text] [Related]
2. Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.
Yu L; Zhao J; Gao L
Int J Biol Sci; 2018; 14(8):971-982. PubMed ID: 29989066
[TBL] [Abstract][Full Text] [Related]
3. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
5. Drug repurposing for breast cancer therapy: Old weapon for new battle.
Aggarwal S; Verma SS; Aggarwal S; Gupta SC
Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
[TBL] [Abstract][Full Text] [Related]
6. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing.
Yang X; Huang WT; Wu HY; He RQ; Ma J; Liu AG; Chen G
Oncol Rep; 2019 Apr; 41(4):2241-2253. PubMed ID: 30816547
[TBL] [Abstract][Full Text] [Related]
7. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
8. Utilizing Cancer - Functional Gene Set - Compound Networks to Identify Putative Drugs for Breast Cancer.
Hsiao TH; Chiu YC; Chen YH; Hsu YC; Chen HH; Chuang EY; Chen Y
Comb Chem High Throughput Screen; 2018; 21(2):74-83. PubMed ID: 29303076
[TBL] [Abstract][Full Text] [Related]
9. Computational Drug-repositioning Approach Identifying Sirolimus as a Potential Therapeutic Option for Inflammatory Dilated Cardiomyopathy.
Shibata K; Endo T; Kuribayashi Y
Drug Res (Stuttg); 2019 Oct; 69(10):565-571. PubMed ID: 31238376
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
Jadamba E; Shin M
Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
[TBL] [Abstract][Full Text] [Related]
11. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
[TBL] [Abstract][Full Text] [Related]
12. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
14. Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
Iwata M; Hirose L; Kohara H; Liao J; Sawada R; Akiyoshi S; Tani K; Yamanishi Y
J Med Chem; 2018 Nov; 61(21):9583-9595. PubMed ID: 30371064
[TBL] [Abstract][Full Text] [Related]
15. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
[TBL] [Abstract][Full Text] [Related]
16. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
17. Drug repurposing by integrated literature mining and drug-gene-disease triangulation.
Sun P; Guo J; Winnenburg R; Baumbach J
Drug Discov Today; 2017 Apr; 22(4):615-619. PubMed ID: 27780789
[TBL] [Abstract][Full Text] [Related]
18. Network controllability solutions for computational drug repurposing using genetic algorithms.
Popescu VB; Kanhaiya K; Năstac DI; Czeizler E; Petre I
Sci Rep; 2022 Jan; 12(1):1437. PubMed ID: 35082323
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning by merging active subnetworks validated in cancer and COVID-19.
Lucchetta M; Pellegrini M
Sci Rep; 2021 Oct; 11(1):19839. PubMed ID: 34615934
[TBL] [Abstract][Full Text] [Related]
20. A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.
Wang L; Li F; Sheng J; Wong ST
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S6. PubMed ID: 26099165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
